Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson’s Disease: A Meta-Analysis
Objective. To investigate the differences of candidate cerebrospinal fluid (CSF) biomarkers associated with multiple system atrophy (MSA) and Parkinson’s disease (PD). Method. Here, a systematic review and meta-analysis were conducted on studies related to CSF biomarkers associated with MSA and PD o...
Saved in:
Main Authors: | Dan Xie, Ling Feng, Hongyan Huang, Quanzhen Zhao, Pingping Ning, Qiuyan Shen, Haitao Lu, Fang Xu, Yanming Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.1155/2021/5559383 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis
by: Ekaterina Martynova, et al.
Published: (2020-01-01) -
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01) -
Cerebrospinal fluid metabolites as potential biomarkers for epilepsy: Insights from genome‐wide association studies
by: Zhenxiang Zhao, et al.
Published: (2025-02-01) -
Changes in Cerebrospinal Fluid Biomarkers in Human Herpesvirus-6-Associated Acute Encephalopathy/Febrile Seizures
by: Naoyuki Tanuma, et al.
Published: (2014-01-01) -
Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson’s disease
by: Stefan Bräuer, et al.
Published: (2025-01-01)